"Global Adult Vaccines Market Overview:
Global Adult Vaccines Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Adult Vaccines Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Adult Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Adult Vaccines Market:
The Adult Vaccines Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Adult Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Adult Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Adult Vaccines market has been segmented into:
Influenza
Tetanus
Diphtheria
Pertussis (Td/Tdap
By Application, Adult Vaccines market has been segmented into:
MMR
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Adult Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Adult Vaccines market.
Top Key Players Covered in Adult Vaccines market are:
GlaxoSmithKline plc
Merck & Co.
Inc.
Pfizer Inc.
Sanofi Pasteur
AstraZeneca
Johnson & Johnson
Novavax
Inc.
Moderna
Inc.
Inovio Pharmaceuticals
Inc.
Bavarian Nordic
Dynavax Technologies Corporation
BioNTech S
Emergent BioSolutions Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Sinovac Biotech Ltd.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Adult Vaccines Market by Type
4.1 Adult Vaccines Market Snapshot and Growth Engine
4.2 Adult Vaccines Market Overview
4.3 Influenza
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Influenza: Geographic Segmentation Analysis
4.4 Tetanus
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Tetanus: Geographic Segmentation Analysis
4.5 Diphtheria
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Diphtheria: Geographic Segmentation Analysis
4.6 Pertussis (Td/Tdap
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Pertussis (Td/Tdap: Geographic Segmentation Analysis
Chapter 5: Adult Vaccines Market by Application
5.1 Adult Vaccines Market Snapshot and Growth Engine
5.2 Adult Vaccines Market Overview
5.3 MMR
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 MMR: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Adult Vaccines Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GLAXOSMITHKLINE PLC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MERCK & CO.
6.4 INC.
6.5 PFIZER INC.
6.6 SANOFI PASTEUR
6.7 ASTRAZENECA
6.8 JOHNSON & JOHNSON
6.9 NOVAVAX
6.10 INC.
6.11 MODERNA
6.12 INC.
6.13 INOVIO PHARMACEUTICALS
6.14 INC.
6.15 BAVARIAN NORDIC
6.16 DYNAVAX TECHNOLOGIES CORPORATION
6.17 BIONTECH S
6.18 EMERGENT BIOSOLUTIONS INC.
6.19 SERUM INSTITUTE OF INDIA PVT. LTD.
6.20 BHARAT BIOTECH
6.21 SINOVAC BIOTECH LTD.
Chapter 7: Global Adult Vaccines Market By Region
7.1 Overview
7.2. North America Adult Vaccines Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Influenza
7.2.4.2 Tetanus
7.2.4.3 Diphtheria
7.2.4.4 Pertussis (Td/Tdap
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 MMR
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Adult Vaccines Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Influenza
7.3.4.2 Tetanus
7.3.4.3 Diphtheria
7.3.4.4 Pertussis (Td/Tdap
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 MMR
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Adult Vaccines Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Influenza
7.4.4.2 Tetanus
7.4.4.3 Diphtheria
7.4.4.4 Pertussis (Td/Tdap
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 MMR
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Adult Vaccines Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Influenza
7.5.4.2 Tetanus
7.5.4.3 Diphtheria
7.5.4.4 Pertussis (Td/Tdap
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 MMR
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Adult Vaccines Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Influenza
7.6.4.2 Tetanus
7.6.4.3 Diphtheria
7.6.4.4 Pertussis (Td/Tdap
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 MMR
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Adult Vaccines Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Influenza
7.7.4.2 Tetanus
7.7.4.3 Diphtheria
7.7.4.4 Pertussis (Td/Tdap
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 MMR
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Adult Vaccines Scope:
|
Report Data
|
Adult Vaccines Market
|
|
Adult Vaccines Market Size in 2025
|
USD XX million
|
|
Adult Vaccines CAGR 2025 - 2032
|
XX%
|
|
Adult Vaccines Base Year
|
2024
|
|
Adult Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur, AstraZeneca, Johnson & Johnson, Novavax, Inc., Moderna, Inc., Inovio Pharmaceuticals, Inc., Bavarian Nordic, Dynavax Technologies Corporation, BioNTech S, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, Sinovac Biotech Ltd..
|
|
Key Segments
|
By Type
Influenza
Tetanus
Diphtheria
Pertussis (Td/Tdap
By Applications
MMR
|
